Evaluation of the Clinical Utility of the APE2 Score in Autoimmune Encephalopathy and Paraneoplastic Antibody Panels

Principal Investigator

Robert Nerenz

Study Number

STUDY02001013

Phase

N/A

Available at the following location(s)

• Lebanon

Do you need help with some of the labels on this page?
Read our glossary of terms